US Patent Issued to JIANGSU TASLY DIYI PHARMACEUTICAL on Dec. 2 for "FXR agonist having pyrazine structure, and preparation method and use" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,259, issued on Dec. 2, was assigned to JIANGSU TASLY DIYI PHARMACEUTICAL Co. LTD. (Jiangsu, China).

"FXR agonist having pyrazine structure, and preparation method and use" was invented by Weiwei Ma (Jiangsu, China) and Guocheng Wang (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel FXR agonist having a pyrazine structure, a preparation method therefor and the use thereof, and in particular relates to a compound as represented by the following general formula (I), or a hydrate, a solvate or a pharmaceutically acceptable salt thereof or a resolved single isomer thereof, which has the effect of treat...